Metformin Use Is Associated With Reduced Mortality in a Diverse Population With COVID-19 and Diabetes
ConclusionThus, these results suggest that while diabetes is an independent risk factor for COVID-19-related mortality, this risk is dramatically reduced in subjects taking metformin prior to diagnosis of COVID-19, raising the possibility that metformin may provide a protective approach in this high risk population.
Source: Frontiers in Endocrinology - Category: Endocrinology Source Type: research
More News: African Health | COVID-19 | Diabetes | Eating Disorders & Weight Management | Electronic Health Records (EHR) | Endocrinology | Fortamet | Health Management | Hypertension | Metformin | Obesity | Pandemics